Coronary Heart Disease Therapy
Scientists at Athens University, Cardiology Department target coronary heart disease therapy
Published in Genetics and Environmental Business Week, March 18th, 2010
New research, 'Genetic polymorphism on type 2 receptor of angiotensin II, modifies cardiovascular risk and systemic inflammation in hypertensive males,' is the subject of a report. "Angiotensin type 2 receptor (AT2R), plays a crucial role in blood pressure regulation and atherogenesis. AT2R gene is located on chromosome X and the biological effect of polymorphism A1675G in this gene needs to be further specified," investigators in Athens, Greece report.
"We examined the impact of A1675G on the risk and the severity of coronary artery disease (CAD), and the expression of proatherogenic inflammatory molecules in hypertensive patients. The study population consisted of 146...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- Antisense Technology
Isis Reports Strong Financial Results and Highlights for 2009 - Argos Therapeutics
Argos Therapeutics Publishes Positive Immune Response, Safety and Manufacturing Data for its Arcelis(TM) HIV Program in Clinical Immunology - BioSante Pharmaceuticals, Inc.
BioSante Pharmaceuticals Receives Two New Patents for Manufacture of Proteins, Including Antibodies - Breast Cancer
Synthetic lethality: a new way to kill cancer cells - CSL Behring
Study Shows C1-Esterase Inhibitor Concentrate Rapidly Relieves Acute, Successive Attacks of Hereditary Angioedema at All Body Sites - Cytovance Biologics LLC
Cytovance(R) Biologics Announces Business Development Focus in International Markets and Promotion of New Vice President of Sales & Business Development - North America - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
